Colon Cancer Clinical Trial

Survivor Choices for Eating and Drinking – Colorectal Cancer

Summary

Epidemiologic data suggest that a Western dietary pattern after diagnosis of colorectal cancer increases risk of disease recurrence and death. High intake of red and processed meat, dairy, refined grains, and sweets/desserts characterize a 'Western dietary pattern'. This study aims to translate the epidemiologic findings into a patient-centered, web-based dietary intervention with text messaging to inform and modify users' dietary choices. The investigators' specific aims are to: 1) Develop a web-based dietary intervention with text messaging for colorectal cancer survivors; and 2) Conduct a 12-week pilot randomized controlled trial to determine the acceptability and feasibility of the dietary intervention among 50 colorectal cancer survivors. All participants will receive standard of care print materials regarding diet following a colorectal cancer diagnosis. Participants in the intervention group will also receive access to a web-based dietary intervention with text messaging for 12 weeks. This study will generate preliminary data on the effect of the intervention on dietary choices among colorectal cancer survivors for future studies.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

diagnosed with colon or rectal adenocarcinoma
completed standard cytotoxic chemotherapy prior to enrollment, if medically indicated
considered disease-free or have stable disease at baseline
able to speak and read English
access to a mobile phone with Internet and text messaging capabilities
able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the Internet

Exclusion Criteria:

Individuals who are already meeting four or more of the six target dietary behaviors will be excluded:

≥5 servings/day of fruits & vegetables
≥3 servings/day of whole grains
≥2 servings/week of fish
no processed meat
no sugar-sweetened beverages
≤1 alcoholic drink/d for women and ≤2 alcoholic drinks/d for men.

Study is for people with:

Colon Cancer

Estimated Enrollment:

50

Study ID:

NCT02965521

Recruitment Status:

Completed

Sponsor:

University of California, San Francisco

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of California, San Francisco
San Francisco California, 94158, United States

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

50

Study ID:

NCT02965521

Recruitment Status:

Completed

Sponsor:


University of California, San Francisco

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider